Eur Urol. 2006 May;49(5):790-7. Epub 2006 Jan 24.

Management of BCG failures in superficial bladder cancer: a review.

Source

Department of Urology, University Medical Centre St. Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands. F.Witjes@uro.umcn.nl

Abstract

OBJECTIVE:

Review management of bacillus Calmette-Guérin (BCG) failures in superficial bladder cancer.

METHOD:

Search of published literature and meeting abstracts.

RESULTS:

Patients in whom BCG fails are not a uniform group. Failure cannot be predicted but high-risk patients can be identified. In case of failure and progression the outcome is bad. Conservative but investigative alternatives are BCG/interferon-alpha, intravesical hyperthermia/chemotherapy, or photodynamic therapy. Standard treatment in failing patients remains cystoprostatectomy.

CONCLUSION:

BCG failures need careful and individualized therapy in experienced hands.

Comment in

Management of BCG "Failures". [Eur Urol. 2006]
Management of BCG "Failures".Palou Redorta J. Eur Urol. 2006 May; 49(5):779-80. Epub 2006 Mar 20.

PMID:: 16464532; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures. [Curr Opin Urol. 2004]
Review Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures.
Joudi FN, O'Donnell MA. Curr Opin Urol. 2004 Sep; 14(5):271-5.
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. [Eur Urol. 2005]
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H. Eur Urol. 2005 Jul; 48(1):53-9; discussion 59. Epub 2005 Apr 7.
Review The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder. [J Urol. 2001]
Review The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.
Kim JC, Steinberg GD. J Urol. 2001 Mar; 165(3):745-56.
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer. [J Urol. 2007]
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP, Tangen CM, Sucharew H, Wood D, Crawford ED. J Urol. 2007 May; 177(5):1727-31.
Management of BCG "Failures". [Eur Urol. 2006]
Management of BCG "Failures".
Palou Redorta J. Eur Urol. 2006 May; 49(5):779-80. Epub 2006 Mar 20.

See reviews... See all...

Cited by 7 PubMed Central articles

Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model. [Oncol Lett. 2011]
Enhanced antitumor effect of combination intravesical mitomycin C and bacillus Calmette-Guerin therapy in an orthotopic bladder cancer model.
Matsushima M, Horinaga M, Fukuyama R, Yanaihara H, Kikuchi E, Kawachi M, Iida M, Nakahira Y, Oya M, Asakura H. Oncol Lett. 2011 Jan; 2(1):13-19. Epub 2010 Nov 23.
BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis. [Cancer Cell Int. 2010]
BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis.
Schwarzer K, Foerster M, Steiner T, Hermann IM, Straube E. Cancer Cell Int. 2010 Jun 29; 10:21. Epub 2010 Jun 29.
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial. [J Transl Med. 2010]
The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.
Burger M, Thiounn N, Denzinger S, Kondas J, Benoit G, Chapado MS, Jimenz-Cruz FJ, Kisbenedek L, Szabo Z, Zsolt D, et al. J Transl Med. 2010 Jun 8; 8:54. Epub 2010 Jun 8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Management of BCG failures in superficial bladder cancer: a review.
Management of BCG failures in superficial bladder cancer: a review.
Eur Urol. 2006 May ;49(5):790-7. Epub 2006 Jan 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: